Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM5 | P41594 | 3/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.42 |
| ▸ | NPC1 | O15118 | 3/20 | 0.42 |
| ▸ | RAB9A | P51151 | 2/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | GBA1 | P04062 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.40 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 3/20 | 0.39 |
| ▸ | CA12 | O43570 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | CA7 | P43166 | 1/20 | 0.38 |
| ▸ | CA9 | Q16790 | 1/20 | 0.38 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.38 |
| ▸ | ACHE | P22303 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9333898 | 0.89 | CA12 (0.44) | KMT2ANPC1RAB9ANPSR1SMN1; SMN2 | |
| SCHEMBL1219902 | 0.82 | CCR1 (0.41) | GRM5KMT2ANPC1RAB9ANPSR1 | |
| SCHEMBL231108 | 0.80 | KDM4E (0.45) | GRM5KMT2ANPC1RAB9ANPSR1 | |
| SCHEMBL1217506 | 0.79 | TGFBR1 (0.36) | KMT2ANPC1RAB9ANPSR1MAPT | |
| SCHEMBL1219437 | 0.79 | CA12 (0.34) | KMT2ANPSR1SMN1; SMN2MEN1CA12 | |
| SCHEMBL1219522 | 0.79 | GRM5 (0.45) | GRM5NPC1RAB9ANPSR1GBA1 | |
| SCHEMBL1219181 | 0.79 | RAB9A (0.40) | GRM5KMT2ANPC1RAB9AGBA1 | |
| SCHEMBL1219260 | 0.79 | TGFBR1 (0.41) | GRM5KMT2ANPC1RAB9AGBA1 | |
| SCHEMBL28509210 | 0.78 | KDM4E (0.44) | GRM5KMT2ANPC1RAB9ANPSR1 | |
| SCHEMBL11903943 | 0.77 | LMNA (0.34) | GRM5KMT2ANPC1RAB9AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2256102-B1 | PROCESS FOR PRODUCTION OF ALKOXYCARBONYL COMPOUND | SUMITOMO CHEMICAL CO (JP) | 2018-09-26 | — | — | EP | disclosed |
| EP-2828232-B1 | PROCESS FOR PRODUCING ALKYL METHACRYLATE | SUMITOMO CHEMICAL CO (JP) | 2016-04-20 | — | — | EP | disclosed |
| EP-2828232-A1 | PROCESS FOR PRODUCING ALKYL METHACRYLATE | Sumitomo Chemical Company Limited (JP) | 2015-01-28 | — | — | EP | disclosed |
| WO-2013141004-A1 | PROCESS FOR PRODUCING ALKYL METHACRYLATE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2013-09-26 | — | — | WO | disclosed |
| US-8399699-B2 | Process for production of alkoxycarbonyl compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2013-03-19 | — | — | US | disclosed |
| US-20110046417-A1 | PROCESS FOR PRODUCTION OF ALKOXYCARBONYL COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-02-24 | — | — | US | disclosed |
| EP-2256102-A1 | PROCESS FOR PRODUCTION OF ALKOXYCARBONYL COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2010-12-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110046417-A1 | PROCESS FOR PRODUCTION OF ALKOXYCARBONYL COMPOUND | ADH1A, NAA50, NAA10 | GRM5 1542/4885KMT2A 402/4885NPC1 2613/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.